UDG Healthcare plc added Erik Van Snippenberg to its board as a nonexecutive director.
Snippenberg was most recently with GlaxoSmithKline Plc as senior vice president and area head for Europe and Canada. He was also a member of GlaxoSmithKline's global pharmaceutical management team.
Meanwhile, UDG Healthcare said Chris Corbin, a nonexecutive director of the company due to retire on April 2019, has agreed to extend his term. Corbin will be subject to re-election at the company's annual general meeting.
The Dublin-based company provides clinical, commercial, communication and packaging services to the healthcare industry.